Ming Lu

6PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersVeterinary diagnosis and diagnostics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 13, 2026
Surufatinib plus toripalimab for patients with advanced solid tumors and disease progression after prior immunotherapy: an open-label multi-cohort phase 2 trial.

|Dec 29, 2025
Surufatinib combined with sintilimab and IBI310 for the treatment of high-grade advanced-neuroendocrine neoplasms: A single arm, open-label, single-center, phase II study.

Panpan Zhang, Miao Zhang, Yakun Wang

|Oct 24, 2019
Prognostic Models for Predicting Overall Survival in Patients with Primary Gastric Cancer: A Systematic Review.

Qi Feng, Margaret T May, Suzanne Ingle

|Jun 22, 2018
A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer.

Qiyue Zhang, Fei Shan, Ziyu Li

|Apr 24, 2018
Clinical and Prognostic Value of PET/CT Imaging with Combination of 68Ga-DOTATATE and 18F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms.

Panpan Zhang, Jiangyuan Yu, Jie Li

|Feb 14, 2018
Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis.

Yakun Wang, Lin Shen, Ming Lu

Pageof 1

Frequent Collaborators

3 joint publications

Lin Shen

1 joint publications

Xiaotian Zhang

1 joint publications

Zhi Yang

1 joint publications

Qi Feng